This observational study shows optimal tacrolimus trough concentrations improve therapeutic efficacy in pediatric patients with HSPN, suggesting tailored treatment strategies.
In pediatric patients with HSPN in China, maintaining tacrolimus trough concentrations within the therapeutic range of 3-5 ng·mL⁻¹ has been demonstrated to achieve optimal therapeutic efficacy.
No takes yet. Share an insight, caveat, or question.
Li et al. (2025) studied this question.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: